Anabolic and catabolic biomarkers as predictors of muscle strength decline: The InCHIANTI study

Rejuvenation Research

Volumn 13, Issue 1, 2010, Pages 3-11

  Stenholm, Sari ^a,b   Maggio, Marcello ^c   Lauretani, Fulvio ^d   Bandinelli, Stefania ^e   Ceda, Gian Paolo ^c   Di Iorio, Angelo ^f   Giallauria, Francesco ^a   Guralnik, Jack M ^a   Ferrucci, Luigi ^a  

^a NATIONAL INSTITUTE ON AGING   (United States)

^b NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^c UNIVERSITY OF PARMA   (Italy)

^d UNIVERSITY HOSPITAL OF PARMA   (Italy)

^e ASF   (Italy)

^f UNIVERSITY OF CHIETI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 6; PRASTERONE SULFATE; SOMATOMEDIN C; TESTOSTERONE; TUMOR NECROSIS FACTOR ALPHA RECEPTOR;

AGED; ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HAND GRIP; HUMAN; MALE; MUSCLE STRENGTH; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN SYNTHESIS;

AGED; BIOLOGICAL MARKERS; FEMALE; HAND STRENGTH; HEALTH SURVEYS; HUMANS; ITALY; LINEAR MODELS; MALE; MUSCLE STRENGTH;

EID: 77949525155     PISSN: 15491684     EISSN: None     Source Type: Journal    
DOI: 10.1089/rej.2009.0891     Document Type: Article

References (37)

1. Rantanen T, Harris T, Leveille SG, Visser M, Foley D, Masaki K, Guralnik JM. Muscle strength and body mass index as long-term predictors of mortality in initially healthy men. J Gerontol A Biol Sci Med Sci 2000;55A:M168-M173.
2. Visser M, Goodpaster BH, Kritchevsky SB, Newman AB, Nevitt M, Rubin SM, Simonsick EM, Harris TB, for the Health ABC Study. Muscle mass, muscle strength, and muscle fat infiltration as predictors of incident mobility limitations in well-functioning older persons. J Gerontol A Biol Sci Med Sci 2005;60:M324-M333.
3. Chan BK, Marshall LM, Winters KM, Faulkner KA, Schwartz AV, Orwoll ES. Incident fall risk and physical activity and physical performance among older men: The Osteoporotic Fractures in Men Study. Am J Epidemiol 2007; 165:696-703.
4. Rolland Y, Czerwinski S, Abellan Van Kan G, Morley JE, Cesari M, Onder G, Woo J, Baumgartner R, Pillard F, Boirie Y, Chumlea WMC, Vellas B. Sarcopenia: Its assessment, etiology, pathogenesis, consequences and future perspectives. J Nutr Health Aging 2008;12:433-450.
5. Schaap LA, Pluijm SM, Deeg DJ, Visser M. Inflammatory markers and loss of muscle mass (sarcopenia) and strength. Am J Med 2006;119:526.e529-526.e517.
6. Taaffe DR, Harris TB, Ferrucci L, Rowe J, Seeman TE. Cross-sectional and prospective relationships of interleukin-6 and C-reactive protein with physical performance in elderly persons: MacArthur studies of successful aging. J Gerontol A Biol Sci Med Sci 2000;55A:M709-M715.
7. Ferrucci L, Penninx BWJH, Volpato S, Harris T, Bandeen-Roche K, Balfour J, Leveille SG, Fried LP, Guralnik JM. Change in muscle strength explains accelerated decline of physical function in older women with high interleukin-6 serum levels. J Am Geriatr Soc 2002;50:1947-1954.
8. Schaap LA, Pluijm SM, Deeg DJ, Harris TB, Kritchevsky SB, Newman AB, Colbert LH, Pahor M, Rubin SM,. Tylavsky FA, Visser M, for the Health ABC Study. Higher inflammatory marker levels in older persons: Associations with 5-year change in muscle mass and muscle strength. J Gerontol A Biol Sci Med Sci 2009;doi:10.1093=gerona=glp097.
9. Visser M, Pahor M, Taaffe DR, Goodpaster BH, Simonsick EM, Newman AB, Nevitt M, Harris TB. Relationship of in-terleukin-6 and tumor necrosis factor-a with muscle mass and muscle strength in elderly men and women: The Health ABC Study. J Gerontol A Biol Sci Med Sci 2002;57A:M326-M332.
10. Reuben DB, Cheh AI, Harris TB, Ferrucci L, Rowe JW, Tracy RP, SeemanTE. Peripheral blood markers of inflammation predict mortality and functional decline in high-functioning community-dwelling older persons. J Am Geriatr Soc 2002;50:638-644.
11. Lamberts SW, van den Beld AW, van der Lely AJ. The endocrinology of aging. Science 1997;278:419-424.
12. Valenti G, Denti L, Maggio M, Ceda G, Volpato S, Bandinelli S, Ceresini G, Anne Cappola A, Guralnik JM, Ferrucci L. Effect of DHEAS on skeletal muscle over the life span: The InCHIANTI study. J Gerontol A Biol Sci Med Sci 2004; 59:466-472.
13. Chu LW, Tam S, Kung AW, Lo S, Fan S, Wong RL, Morley JE, Lam KSL. Serum total and bioavailable testosterone levels, central obesity, and muscle strength changes with aging in healthy Chinese men. J Am Geriatr Soc 2008;56: 1286-1291.
14. Araujo AB, Travison TG, Bhasin S, Esche GR, Williams RE, Clark RV, McKinlay JB. Association between testosterone and estradiol and age-related decline in physical function in a diverse sample of men. J Am Geriatr Soc 2008;56:2000-2008.
15. Schaap LA, Pluijm SM, Deeg DJ, Penninx BW, Nicklas BJ, Lips P, Harris TB, Newman AB, Kritchevsky SB, Cauley JA, Goodpaster BH, Tylavsky FA, Yaffe K, Visser M. for the Health ABC Study. Low testosterone levels and decline in physical performance and muscle strength in older men: findings from two prospective cohort studies. Clin En-docrinol (Oxf) 2008;68:42-50.
16. Cappola AR, Xue QL, Fried LP. Multiple hormonal deficiencies in anabolic hormones are found in frail older women: The Women's Health and Aging studies. J Gerontol A Biol Sci Med Sci 2009;64:243-248.
17. Peolsson A, Hedlund R, Oberg B. Intra-and inter-tester reliability and reference values for hand strength. J Rehabil Med 2001;33:36-41.
18. Rantanen T, Era P, Kauppinen M, Heikkinen E. Maximal isometric muscle strength and socioeconomic status, health, and physical activity in 75-year-old persons. J Aging Phys Act 1994;2:206-220.
19. Ferrucci L, Bandinelli S, Benvenuti E, Di Iorio A, Macci C, Harris TB, Guralnik JM. Subsystems contributing to the decline in ability to walk: Bridging the gap between epidemiology and geriatric practice in the InCHIANTI study. J Am Geriatr Soc 2000;48:1618-1625.
20. Lauretani F, Russo C, Bandinelli S, Bartali B, Cavazzini C, Di Iorio A, Corsi AM, Rantanen T, Guralnik JM, Ferrucci L. Age-associated changes in skeletal muscles and their effect on mobility: An operational diagnosis of sarcopenia. J Appl Physiol 2003;95:1851-1860.
21. Guralnik JM, Ferrucci L, Simonsick EM, Salive ME, Wallace RB. Lower-extremity function in persons over the age of 70 years as a predictor of subsequent disability. N Engl J Med 1995;332:556-561.
22. Guralnik JM, Ferrucci L, Pieper CF, Leveille SG, Markides KS, Ostir GV, Stephanie Studenski S, Berkman LF, Wallace RB. Lower extremity function and subsequent disability: Consistency across studies, predictive models, and value of gait speed alone compared with the Short Physical Performance Battery. J Gerontol A Biol Sci Med Sci 2000;55A: M221-M231.
23. Cesari M, Kritchevsky SB, Penninx BW, Nicklas BJ, Simon-sick EM, Newman AB, Tylavsky FA, Brach JS, Satterfield S, Bauer DC, Visser M, Rubin SM, Harris TB, Pahor M. Prognostic value of usual gait speed in well-functioning older people: Results from the Health, Aging and Body Composition Study. J Am Geriatr Soc 2005;53:1675-1680.
24. Guralnik J, Fried L, Simonsick E, Kasper J, Lafferty M. The Women's Health and Aging Study: Health and Social Characteristics of Older Women with Disability. National Institute on Aging, NIH Publication No. 95-4009, Bethesda, MD, 1995.
25. Wareham NJ, Jakes RW, Rennie KL, Mitchell J, Hennings S, Day NE. Validity and repeatability of the EPIC-Norfolk Physical Activity Questionnaire. Int J Epidemiol 2002;31: 168-174.
26. Verbeke G, Molenberghs G. Linear Mixed Models for Longitudinal Data, 2nd edition. Springer-Verlag, New York, 2001.
27. Edwards LJ. Modern statistical techniques for the analysis of longitudinal data in biomedical research. Pediatr Pulmonol 2000;30:330-344.
28. Roth SM, Metter EJ, Ling S, Ferrucci L. Inflammatory factors in age-related muscle wasting. Curr Opin Rheumatol 2006; 18:625-630.
29. Ishii-Yonemoto T, Masuzaki H, Yasue S, Okada S, Kozuka C, Tanaka T, Noguchi M, Tomita T, JFujikura J, Yamamoto Y, Ebihara K, Hosoda K, Nakao K. Glucocorticoid ream-plification within cells intensifies NF{kappa}B and MAPK signaling and reinforces inflammation in activated preadi-pocytes. Am J Physiol Endocrinol Metab 2009; doi:10.1152= ajpendo.00320.2009.
30. Abeywardena MY, Leifert WR, Warnes KE, Varghese JN, Head RJ. Cardiovascular biology of interleukin-6. Curr Pharm Des 2009; 15: 1809-1821.
31. Latham N, Anderson C, Bennett D, Stretton C. Progressive resistance strength training for physical disability in older people. Cochrane Database Syst Rev 2003:CD002759.
32. Geffken DF, Cushman M, Burke GL, Polak JF, Sakkinen PA, Tracy RP. Association between physical activity and markers of inflammation in a healthy elderly population. Am J Epidemiol 2001;153:242-250.
33. Kelley GA, Kelley KS. Effects of aerobic exercise on C-reactive protein, body composition, and maximum oxygen consumption in adults: A meta-analysis of randomized controlled trials. Metabolism 2006;55:1500-1507.
34. Lakka TA, Lakka HM, Rankinen T, Leon AS, Rao DC, Skinner JS, Wilmore JH, Bouchard C. Effect of exercise training on plasma levels of C-reactive protein in healthy adults: The HERITAGE Family Study. Eur Heart J 2005;26:2018-2025.
35. Thompson AM, Mikus CR, Rodarte RQ, Distefano B, Priest EL, Sinclair E, Earnest CP, Blair SN, Church TS. Inflammation and exercise (INFLAME): Study rationale, design, and methods. Contemp Clin Trials 2008; 29:418-427.
36. Nafziger AN, Bowlin SJ, Jenkins PL, Pearson TA. Longitudinal changes in dehydroepiandrosterone concentrations in men and women. J Lab Clin Med 1998;131:316-323.
37. Yen SS. Dehydroepiandrosterone sulfate and longevity: New clues for an old friend. Proc Natl Acad Sci USA 2001;98:8167-8169.